25 06, 2025 Zhasmina Mihaylova et al., Clinically Based Cetuximab Re-Challenge in Patients with RAS Wild-Type Metastatic Colorectal Cancer and Retrospective Analysis of Liquid Biopsies—Preliminary Data. adlitterio663392025-06-25T16:31:03+02:00 Read More
19 06, 2025 Marianna Peroni et al., BRAF fusion as resistance mechanism to osimertinib in EGFR-mutated NSCLC: a case report and review of literature adlitterio663392025-06-19T16:29:03+02:00 Read More
28 05, 2025 Maria Antonietta Castaldi et al., BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient adlitterio663392025-05-28T16:22:02+02:00 Read More
20 05, 2025 Mariavittoria Vescovo et al., Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications adlitterio663392025-05-20T16:17:56+02:00 Read More
7 05, 2025 Laura Antolino et al., TP53 Arg72Pro Polymorphism and Pancreatic Cancer Susceptibility: Assessing rs1042522 as a Risk Factor for Pancreatic Cancer adlitterio663392025-05-07T16:16:46+02:00 Read More
27 01, 2025 Elisabetta Maffei et al., Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers adlitterio663392025-01-27T15:07:22+01:00 Read More
21 12, 2024 Carlotta Ceccon et al., MLH1 gene promoter methylation status partially overlaps with CpG methylator phenotype (CIMP) in colorectal adenocarcinoma adlitterio663392024-12-21T14:44:30+01:00 Read More
29 11, 2024 Ilaria Proietti et al., BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy adlitterio663392024-11-29T14:16:14+01:00 Read More
17 10, 2024 Andrea Boscolo Bragadin et al., Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer adlitterio663392024-10-17T11:21:01+02:00 Read More
30 09, 2024 Silvia Snider et al., Pre-operative mean platelet volume is associated with overall survival in patients with IDH-wildtype glioblastoma undergoing maximal safe resection adlitterio663392025-01-02T11:11:13+01:00 Read More
